Pharmaceutical quality assessment - The new chemistry, manufacturing, and controls (CMC) review paradigm in the 21st century
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Presentation
- By: NASR, Moheb (US FDA, Office of New Drug Chemistry (ONDC), Rockville, MD, United States of America)
The U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research, Office of New Drug Chemistry (ONDC) is responsible for reviewing the chemistry, manufacturing, and controls (CMC) section of new drug applications. Consistent with the FDA’s initiative concerning modernization of the regulation of pharmaceutical manufacturing.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.